Kidney Cancer is a gold open access journal. This means that every article, from the time it is first posted as a pre-press article to when it is included as part of an online volume, is immediately, permanently, and openly available for readers to view, download, share, and reuse.
Authors will be required to pay an open access fee of US$500 / €500 to publish under the CC BY-NC 4.0 license on acceptance for publication.
Publishing under the CC BY 4.0 license is available at US$750 / €750 (ex. VAT if applicable).
Authors who envisage difficulties paying the article processing charge may appeal to the Editors-in-chief to discuss waiving the charge. Waivers are also available for corresponding authors from eligible countries as identified by Research4Life project. A fee waiver may also be available if your institution has a transformative agreement with IOS Press.
This journal deposits open access articles in PubMedCentral (PMC) as part of the IOS Press Open Library but can only do so if the article received NIH funding or if any of the authors are NIH, or associated partners, employees.
Authors should identify NIH funding in the Funding statement in their work.
Please refer to the PMC Funder Deposit List at the NIH Public Access Policy for details.